Evidence mapPaperPMID 41529238Full record

ArticleJMIR diabetes2026

Continuous Ketone Monitoring: Data From a Randomized Controlled Trial.

Simon K Kjær, Lukas Ochsner Reynaud Ridder, Mads Svart, Nikolaj Rittig, Lise Nørkjær Bjerg, Birgitte Sandfeld-Paulsen, Henrik Holm Thomsen

Abstract read
In one paragraph

Article in JMIR diabetes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Simon K KjærSteno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.ORCID http://orcid.org/0009-0006-3537-7619
Lukas Ochsner Reynaud RidderDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0003-1110-748X
Mads SvartDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0002-9574-0612
Nikolaj RittigSteno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.ORCID http://orcid.org/0000-0001-9938-2181
Lise Nørkjær BjergDepartment of Clinical Biochemistry, Regional Hospital Central Jutland, Viborg, Denmark.ORCID http://orcid.org/0000-0002-0133-5131
Birgitte Sandfeld-PaulsenDepartment of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.ORCID http://orcid.org/0000-0001-9884-9165
Henrik Holm ThomsenDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0003-0522-0320

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Unlabelled: In our study, a commercially available continuous ketone monitoring device captured β-Hydroxybutyrate (BHB) dynamics during exogenous ketosis but revealed a gradual decline day-to-day BHB concentrations over 14 days in both ketone ester and placebo groups, likely reflecting sensor drift.

Indexed as

beta-hydroxybutyratecontinuous ketone monitoringexogenous ketosisketone esterketone sensor technology

Identifiers

PMID41529238
PMCPMC12799078

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.